--- title: "இந்தியாவில் GLP-1 பற்றி மருத்துவரிடம் எவ்வாறு பேசுவது" description: "Productive GLP-1 consultation India—question, record, cost, safety, expectation. Medically reviewed, CDSCO-aware guides for Indian patients. Kesho does not…" canonical: "https://www.kesho.health/ta/blog/how-to-talk-to-doctor-glp-1-india" markdown_url: "https://www.kesho.health/md/ta/blog/how-to-talk-to-doctor-glp-1-india" date_published: "Jun 15, 2026" date_modified: "Jun 26, 2026" author: "Dr. Ananya Mehta" language: "ta-IN" primary_keyword: "talk to doctor GLP-1 India" --- # இந்தியாவில் GLP-1 பற்றி மருத்துவரிடம் எவ்வாறு பேசுவது > **Short answer:** Recent lab (HbA1c, lipid, kidney, liver), weight history, medication list consultation. Indication, titration, side effect, cost, monitoring ask. GLP-1 drug-class conversation—brand request அல்ல. Monthly budget early discuss. Clinic leave before follow-up schedule. Kesho educate only—endocrinologist/internal medicine/cardiologist CDSCO Schedule H prescribe. NMC-registered doctor valid prescription இல்லாமல் online GLP-1 வாங்க வேண்டாம். **Canonical HTML:** https://www.kesho.health/ta/blog/how-to-talk-to-doctor-glp-1-india **Markdown:** https://www.kesho.health/md/ta/blog/how-to-talk-to-doctor-glp-1-india *Fifteen-minute consultation prepared arrive further. Diabetes, obesity, both GLP-1 explore—conversation framework Indian patient doctor partner, prescription demand அல்ல. Doctor time respect, missing investigation repeat visit reduce, titration/cost/long-term commitment realistic expectation—mostly out-of-pocket GLP-1. Drug-class literacy, organised lab, honest budget productive incretin consultation hallmark. Unverified telehealth guarantee avoid; NMC physician, CDSCO pharmacy, first injection follow-up.* *Reviewed by Dr. Ananya Mehta, MD, DM Endocrinology. This article has been reviewed by our medical advisory team, including endocrinologists, internal medicine specialists, and cardiologists, and is based on current scientific evidence and Indian clinical guidelines. Last reviewed: June 2026.* ## Key takeaways - Organised lab, weight history, full medication list—including ayurvedic supplement—limited consultation time maximise. - GLP-1 drug-class conversation (semaglutide, tirzepatide, other GLP-1 RA) frame—social media specific brand request not. - Titration schedule, nausea management, monitoring lab, monthly cost, urgent contact symptom explicitly ask. - Monthly medication budget early discuss—India mostly out-of-pocket market adherence, long-term outcome affect. - CDSCO-approved product licenced pharmacy prescription fill; clinic leave before follow-up schedule. ## At a glance (India) | Field | Value | | --- | --- | | Ideal first appointment length | 30–45 minutes for new GLP-1 consults | | Labs to bring | HbA1c, lipids, kidney/liver, thyroid | | Who typically prescribes | Endocrinologist or diabetologist | | Medicine schedule | Schedule H (prescription only) | | Cost range to discuss | ₹8,000–₹25,000/month typical | | First follow-up timing | Often ~4 weeks after start or dose change | ## In this article - Choosing the right specialist - Records to bring - Questions worth asking - Discussing cost honestly - Safety and monitoring topics - Telemedicine and tier-2 access - What to avoid saying - After the appointment - Follow-up and adherence - Obesity without diabetes - Family at the consultation - Polypharmacy discussions - Switching doctors mid-therapy - Pregnancy and lifestyle goals - When to seek a second opinion - Using Kesho assessment tools - Corporate insurance conversations - Documenting informed consent - Building long-term care relationships - Red flags in telehealth prescribing ## India GLP-1 therapy which doctor see? Endocrinologist, internal medicine specialist, cardiologist incretin therapy experience—diabetes, obesity, cardiovascular risk already manage specialist start. Complex obesity polypharmacy, thyroid history, insulin combination endocrinology input warrant. Tier-2 city metro specialist teleconsultation local monitoring follow increasingly common. National Medical Commission (NMC) registered doctor verify. Brief online form guaranteed GLP-1 prescription promise platform avoid—ethical prescribing proper evaluation require. PCOS, fatty liver, cardiovascular disease upfront mention specialty coordinate as needed. RSSDI clinical pathway glycaemic target unmet GLP-1 RA position; obesity-only consultation ICMR BMI threshold South Asian population adapt follow. ### India GLP-1 therapy typically manage who - Provider: Diabetologist / endocrinologist — Best for: GLP-1 initiation, titration, complex cases — Limitation: Metro longer wait - Provider: General physician — Best for: Straightforward T2D stable background meds — Limitation: Obesity-only/MEN2 history refer may - Provider: Teleconsult specialist — Best for: Tier-2 access, second opinion — Limitation: Local lab, injection support need - Provider: Unverified online sellers — Best for: None—avoid — Limitation: Illegal Schedule H dispensing, counterfeit risk ## Bring record, information what? Recent investigation organise: HbA1c (ideally 3 month within), fasting/post-prandial glucose, lipid panel, liver/kidney function, thyroid profile, ultrasound fatty liver any. Weight log available, all medicine including ayurvedic supplement list, diabetes/thyroid cancer/pancreatitis family history, prior diet/weight-loss attempt note. Allergy, injection phobia note. Online GLP-1 research question bring—demand not. Indian doctor drug-class language (semaglutide, tirzepatide, liraglutide) brand marketing slogan rather appreciate. Self-write one-page summary unrelated report stack hand more help. Goal partnership phrase: "Type 2 diabetes, weight GLP-1 RA read. HbA1c 8.1, BMI 28 given—this class appropriate discuss could we?" ## Doctor essential question ask? BMI, HbA1c, comorbidity GLP-1 therapy candidate? Profile fit molecule—semaglutide, tirzepatide, other GLP-1 RA? Titration schedule, nausea manage how? Monitoring lab how often? Estimated monthly cost, generic option? How long continue plan? Travel/miss dose? Current diabetes medicine adjust? Lifestyle target medication accompany? Urgent contact symptom? Answer write—clinic visit after memory fade. Appointment between side effect contact who: clinic nurse, WhatsApp triage, emergency department ask. ### Consultation checklist: question why matter - Question: Am I eligible? — Why it matters: ICMR/RSSDI threshold Western calculator differ - Question: Which molecule and route? — Why it matters: Oral vs injectable cost, adherence affect - Question: Titration plan? — Why it matters: Dose rush nausea, drop-out cause - Question: Monthly cost estimate? — Why it matters: India out-of-pocket affordability adherence drive - Question: Monitoring schedule? — Why it matters: HbA1c, kidney function, thyroid as indicated - Question: Emergency symptoms? — Why it matters: Pancreatitis, severe GI clear rules need ## Honest cost conversation how? Indian doctor sometimes cost under-discuss patient refill unable return. Monthly medication budget openly state—₹8,000 vs ₹20,000 viable option change. Generic semaglutide, dose titration cost spread, oral vs injectable semaglutide wallet affect ask. Affordability limited intensive lifestyle support/older lower price GLP-1 RA discuss. Abrupt stop clinical progress waste; day one planning matter. Employer insurance/CGHS panel diabetes any GLP-1 RA cover—HR verbal not written confirmation. Cost intermittent dosing force say so; doctor sub-therapeutic use rather not start may recommend. ## Safety, monitoring topic cover? MTC, MEN2, pancreatitis, gallbladder disease, severe GI disorder personal/family history discuss. Current medicine GLP-1 interact—sulfonylurea, insulin hypoglycaemia risk rise especially. Pregnancy plan clarify; pregnancy GLP-1 RA not use. Diabetic retinopathy exist rapid glucose improvement ophthalmology monitoring warrant may. CDSCO class warning every approved product class—not one brand only. Injection technique, Indian heat storage, travel written aftercare request. Safety conversation scare tactic not; mild nausea persist vs call when recognise help. ## Frequently asked questions ### Will my GP prescribe GLP-1? Some GPs prescribe for straightforward type 2 diabetes; many refer to specialists for GLP-1 initiation. Complex obesity, thyroid history, polypharmacy, or prior intolerance usually warrant endocrinology referral. Bring organised labs to GP visits so referrals include complete data. ### How long is the first appointment? Allow 30–45 minutes for new GLP-1 consultations including history, examination, counselling, and injection teaching if applicable. Rushed visits leave titration and cost questions unanswered—book adequate time or schedule a follow-up counselling slot. ### Can I get a second opinion? Yes. Bring records to avoid repeat tests. Ethical second opinions evaluate your case—not sell medication packages. A second endocrinologist may agree or disagree; both outcomes are valid when based on complete labs and history. ### Should I stop metformin before asking about GLP-1? No. Continue prescribed medicines unless your doctor advises otherwise. GLP-1 is often added to metformin. ### What if my doctor says no? Ask for specific reasons and a re-evaluation timeline. Improve lifestyle targets, optimise existing medicines, and revisit when criteria change. Declination is often temporary when lifestyle documentation or labs improve over three to six months. ### Is telemedicine adequate for GLP-1 starts? Initial prescribing via telemedicine occurs in India, but physical examination and baseline labs are important. Hybrid models with local lab and follow-up work well. ### Should I bring a family member to my GLP-1 consultation? Family attendance helps when cost and injection reminders are shared responsibilities. Request private time with your doctor for sensitive mental health, pregnancy, or thyroid cancer family history if needed. ### How do I verify my doctor is qualified to prescribe GLP-1? Confirm NMC registration and specialist credentials in endocrinology or diabetology for complex cases. Schedule H prescriptions must come from registered medical practitioners—not wellness coaches or pharmacists acting as prescribers. Verify CDSCO-approved product names on prescriptions before pharmacy visits. ## People also ask ### Will my GP prescribe GLP-1 therapy? Some general physicians prescribe for straightforward type 2 diabetes; many refer to specialists for GLP-1 initiation. Complex obesity, thyroid history, polypharmacy, or prior intolerance usually warrant endocrinology referral. ### How long should the first GLP-1 appointment be? Allow 30–45 minutes for new consultations including history, examination, counselling, and injection teaching if applicable. Rushed visits lead to unanswered questions about titration and cost. ### Can I get a second opinion about GLP-1 therapy? Yes. Bring existing records to avoid repeat tests. Ethical second opinions evaluate your case and explain alternatives—they should not sell medication packages or guarantee prescriptions. ### Should I stop metformin before asking about GLP-1? No. Continue prescribed medicines unless your doctor advises otherwise. GLP-1 receptor agonists are often added to metformin rather than replacing first-line therapy immediately. ### What if my doctor says GLP-1 is not appropriate for me? Ask for specific reasons and a re-evaluation timeline. Improve lifestyle targets, optimise existing medicines, and revisit when criteria change—weight, HbA1c, or comorbidities may shift eligibility. ### Is telemedicine adequate for starting GLP-1 in India? Initial prescribing via telemedicine occurs, but physical examination and baseline labs are important. Hybrid models—teleconsult with metro specialist plus local lab and nurse-led injection training—work well for tier-2 patients. ### What should I not say in the consultation? Avoid claiming you "qualify" based on online calculators, demanding brands from influencers, withholding family cancer history, or expecting antibiotics-style quick fixes. Partnership language works better than demands. ### How do I verify my GLP-1 prescription is legitimate? The medicine must be Schedule H with a valid prescription, CDSCO-approved labelling, batch number, and expiry. Purchase only from licensed pharmacies—never parallel imports or unverified online sellers. ### Should I mention mental health or eating history? Yes. Disclose history of eating disorders, depression, or binge patterns if relevant. GLP-1 therapy affects appetite profoundly; your doctor needs full context to monitor safely and coordinate care. ### When should I call the doctor urgently after starting GLP-1? Persistent vomiting, severe abdominal pain, signs of allergic reaction, suspected hypoglycaemia, or jaundice require prompt contact. Clarify emergency numbers and after-hours coverage at your first visit. ### Can I record my doctor's GLP-1 counselling session? Hospital policies vary—ask permission before recording. Written titration schedules and patient leaflets from CDSCO-approved packaging are safer documentation than covert recordings that may violate clinic rules. ### What if my doctor only has five minutes for my GLP-1 question? Book a dedicated GLP-1 counselling slot or tele-follow-up for titration and cost details. Arrive with a one-page summary and three prioritised questions to maximise brief windows. ### How do I follow up if my doctor is in another city? Hybrid care works: metro specialist for titration, local physician for intercurrent illness and repeat labs. Ensure valid transfer notes and prescription continuity. Schedule quarterly video or in-person reviews for dose changes. ### What documents should I email before a teleconsult? Send recent HbA1c, fasting glucose, lipid panel, kidney and liver tests, current medication list including supplements, weight trend, and prior lifestyle programme notes. Clear phone photos of lab reports are acceptable if originals are unavailable. Organised files reduce repeat testing and speed titration planning during teleconsult follow-up. ## References 1. [RSSDI Clinical Practice Recommendations for Management of Type 2 Diabetes Mellitus (2023).](https://rssdi.in/) 2. [NMC Ethics Regulations for Registered Medical Practitioners.](https://www.nmc.org.in/) 3. [ICMR Expert Group. (2024). National Guidelines for Obesity Management in India.](https://www.icmr.gov.in/) 4. [CDSCO. Schedule H and Prescription Drug Advisories.](https://cdsco.gov.in/) ## Related guides - [who-qualifies-glp-1-india](https://www.kesho.health/blog/who-qualifies-glp-1-india) · [MD](https://www.kesho.health/md/blog/who-qualifies-glp-1-india) - [glp-1-explained-india](https://www.kesho.health/blog/glp-1-explained-india) · [MD](https://www.kesho.health/md/blog/glp-1-explained-india) - [glp-1-cost-india-2026](https://www.kesho.health/blog/glp-1-cost-india-2026) · [MD](https://www.kesho.health/md/blog/glp-1-cost-india-2026) - [cdsco-glp-1-advisory-explained](https://www.kesho.health/blog/cdsco-glp-1-advisory-explained) · [MD](https://www.kesho.health/md/blog/cdsco-glp-1-advisory-explained) --- *Kesho provides GLP-1 education only. We do not prescribe or sell medications. [Editorial policy](https://www.kesho.health/editorial-policy).*